Key result
TMVR emerges as a promising alternative to conventional surgery in severe mitral annular calcification.
Why the study?
Mitral annular calcification complicates treatment of significant mitral valve disease and poses risks with surgical and transcatheter interventions, requiring evaluation of new solutions.
Answers are grounded in this paper and cite their sources.
TMVR offers a promising, less invasive alternative to surgery for high-risk patients with severe mitral valve disease and mitral annular calcification.
Mitral annular calcification (MAC) is a chronic process involving mitral valve annulus, linked with an increased cardiovascular mortality and morbidity. Since its first autoptic description, a progressive evolution in diagnostic tools brought cardiac computed tomography (CT) scan to become the gold standard in MAC detection and classification. The treatment of significant mitral valve disease in patients with annular calcifications has always represented an issue for cardiac surgeons, being it linked with an increased risk of atrioventricular groove rupture, circumflex artery injury, or embolism. As a consequence, different surgical techniques have been developed over time in order to reduce the incidence of these fearsome complications. Recently, transcatheter mitral valve replacement (TMVR) has emerged as a valid alternative to surgery in high-risk patients. Both hybrid transatrial, transfemoral, or transapical approaches have been described to deliver balloon-expandable or self-expanding aortic transcatheter valves into the calcified annulus, with conflicting early and long-term results. Tendyne (Abbott Structural Heart, Santa Clara, CA, USA) is a promising transapical-delivered option. Early results have shown effectiveness and safety of this device in patients with MAC and severe mitral valve disease, with the lowest rate of embolization, mortality, and left ventricular outflow tract obstruction (LVOTO) reported so far.
No takes yet. Share an insight, caveat, or question.
Ascione et al. (2022) conducted a review in Mitral annular calcification with significant mitral valve disease. Transcatheter mitral valve replacement (TMVR) and surgical interventions was evaluated. Transcatheter mitral valve replacement, particularly with the Tendyne system, has emerged as a promising alternative to conventional surgery for high-risk patients with severe mitral annular calcification.
Synapse has enriched 10 related papers. Consider them for comparative context: